Polypharmacy Used to Treat Patient With GIST
Clinicians need to be adept at handling cases in which various teams have prescribed a number of drugs that interact in an unintended manner.
GIST Insights
The Challenges of Diagnosing and Treating Duodenal GISTs
Duodenal GISTs are sometimes difficult to define anatomically and surgical resection may prove challenging.
Case Study Highlights Small Intestinal GIST and Intussusception
Small intestinal GIST and intussusception is an exceedingly rare occurrence and can be difficult to diagnose.
How Can Adherence to Imatinib Therapy in Patients With GIST Be Improved?
To improve adherence to treatment regimens prescribed, we first need to understand the underlying concerns of patients.
The Multifaceted Challenges of Treating GIST in Pediatric Patients
There are a few major hurdles physicians have to navigate when treating pediatric patients with gastrointestinal stromal tumors.
Can Artificial Intelligence Be Used to Predict Malignant Potential in GIST?
Artificial intelligence has been shown to have good predictive value for the malignant potential of gastrointestinal stromal tumors.
Beyond Imatinib: Next-Generation TKIs for the Treatment of GIST
Recently developed TKIs such as ripretinib and avapritinib have the potential to change the treatment landscape of GIST.
Diagnosing GIST Preoperatively: Challenges and Advantages
Various studies have analyzed how to better diagnose gastrointestinal stromal tumors at the preoperative stage.
Should Imatinib Be Discontinued in Patients With Advanced GIST?
We explore how imatinib became the first-line therapy for metastatic GIST, and whether it should be discontinued in some circumstances.
Targeting the PDGF/PDGFR Pathway in Cancer Research
We discuss current therapeutic strategies in targeting the PDGF/PDGFR signaling pathway in cancer research.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in GIST Insights
Loading... 
Loading...